The RDTs gave positive results in 52.3% (228/436) of cases with ParacheckTM-Pf, 57.8% (252/436) with SD Bioline malaria Ag-Pf and 58.0% (253/436) with SD Bioline malaria Ag-Pf/pan. This evidence concerns the gene RENBP and malaria.